Global Access Tanner Pharma operates across 150+ countries with patient access programs and clinical trial logistics, presenting a scalable solution for pharma partners seeking broad global reach and compliant trial-to-treatment transitions.

Early Access Growth Recent launches of global Early Access programs for FAP patients and partnerships with oncology firms indicate demand for compassionate use pathways and expanded access initiatives that can be offered to prospective clients.

Strategic Partnerships Active collaborations with Agenus and ORPHELIA Pharma, plus trial sourcing and logistics capabilities, create opportunities to cross-sell comprehensive access solutions to biotechnology and specialty pharma companies.

Cold Chain Capabilities Expansion into -80°C freezer storage demonstrates capacity to handle temperature-sensitive biologics, enabling Tanner to target partners with complex supply chain requirements and rare/difficult-to-store therapies.

Recognition & Growth Industry recognition as a Best Place to Work and steady revenue in the mid-range position provide credibility for strategic sales discussions with potential customers seeking reliable, people-focused service providers.